Full Text View
Tabular View
No Study Results Posted
Related Studies
Lurasidone HCI - A 6-week Phase 3 Study of Patients With Bipolar I Depression (PREVAIL3)
This study has been completed.
Study NCT01284517   Information provided by Sunovion

First Received on January 25, 2011.   Last Updated on August 29, 2012   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Bipolar Depression
Additional conditions recognized in this trial
Bipolar Disorder
Depression
Depressive Disorder
More general conditions related to this trial
Affective Disorders, Psychotic
Behavioral Symptoms
Mental Disorders
Mood Disorders
Interventions listed in this trial
Lurasidone
Placebo
Sponsors listed in this trial
Sunovion


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services